Detalhe da pesquisa
1.
A randomised, placebo-controlled study of omipalisib (PI3K/mTOR) in idiopathic pulmonary fibrosis.
Eur Respir J
; 53(3)2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30765508
2.
Review of the British Thoracic Society Winter Meeting 2017, 6-8 December 2017, London, UK.
Thorax
; 73(9): 872-876, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-29903754
3.
Review of the British Thoracic Society Winter Meeting 2016, 7-9 December, London, UK.
Thorax
; 72(7): 600-665, 2017 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28473505
4.
Exploration of a potent PI3 kinase/mTOR inhibitor as a novel anti-fibrotic agent in IPF.
Thorax
; 71(8): 701-11, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27103349
5.
Author Correction: The mTORC1/4E-BP1 axis represents a critical signaling node during fibrogenesis.
Nat Commun
; 11(1): 4680, 2020 Sep 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32917879
6.
mTORC1 amplifies the ATF4-dependent de novo serine-glycine pathway to supply glycine during TGF-ß1-induced collagen biosynthesis.
Sci Signal
; 12(582)2019 05 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-31113850
7.
The mTORC1/4E-BP1 axis represents a critical signaling node during fibrogenesis.
Nat Commun
; 10(1): 6, 2019 01 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30602778
8.
A structurally distinct TGF-ß mimic from an intestinal helminth parasite potently induces regulatory T cells.
Nat Commun
; 8(1): 1741, 2017 11 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-29170498
9.
The treatment of idiopathic pulmonary fibrosis.
F1000Prime Rep
; 6: 16, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24669297
10.
Reducing lung function decline in patients with idiopathic pulmonary fibrosis: potential of nintedanib.
Drug Des Devel Ther
; 7: 503-10, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23818761